{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:46:07Z","timestamp":1791809167310,"version":"4.3.4"},"reference-count":46,"publisher":"Emerald","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,13]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study aims to estimate the prevalence of inadequate opioid agonist therapy (OAT) uptake and explore associated factors among people who use nonmedical opioids inside prisons in Iran.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design\/methodology\/approach<\/jats:title>\n                    <jats:p>Using data from a national bio-behavioral surveillance survey, the authors conducted a multi-stage random sampling of 5,785 people in prison in 33 major prisons. Of these, 2994 (51.8%) participants with regular (i.e. at least weekly) nonmedical opioid use in the past month before entering prison or in the previous month inside the prison or prior OAT access before or during incarceration were eligible. The authors built multivariable logistic regression models to assess factors associated with limited OAT uptake inside prisons, reporting adjusted odds ratio (aOR) with 95% confidence intervals (CI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>Participants averaged 36.1\u2009years (SD: 8.6); 97.2% were male. Overall, 32.5% (95% CI: 30.8%, 34.2%) of eligible participants for receiving OAT inside prison, had no OAT uptake. Of those previously on OAT, 40.8% discontinued treatment after incarceration. Factors associated with no OAT uptake included: age\u2009\u2264\u200930 (aOR\u2009=\u20091.74; 95% CI: 1.47, 2.07), recent prison drug use (aOR\u2009=\u20091.56; 95% CI: 1.29, 1.88), insufficient HIV knowledge (aOR\u2009=\u20091.67; 95% CI: 1.32, 2.11). Protective factors included lifetime injection drug use history (aOR\u2009=\u20090.43; 95% CI: 0.34, 0.55), HIV testing history (aOR\u2009=\u20090.78; 95% CI: 0.66, 0.92) and current depression\/anxiety (aOR\u2009=\u20090.61; 95% CI: 0.52, 0.72).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Originality\/value<\/jats:title>\n                    <jats:p>Despite OAT availability in Iranian prisons, one-third of eligible participants did not access treatment. Prior harm reduction engagement was consistently associated with uptake, supporting the need for systematic screening at prison entry, strengthened community-to-prison care continuity and integrated mental health services.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1108\/ijoph-10-2025-0087","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T04:59:41Z","timestamp":1781758781000},"page":"451-463","source":"Crossref","is-referenced-by-count":0,"title":["Unmet needs for opioid agonist therapy in Iranian prisons: a cross-sectional study"],"prefix":"10.1108","volume":"22","author":[{"given":"Mahkameh","family":"Rafiee","sequence":"first","affiliation":[{"name":"Kerman University of Medical Sciences HIV\/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, , Kerman, , and Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran","place":["Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheil","family":"Mehmandoost","sequence":"additional","affiliation":[{"name":"Kerman University of Medical Sciences HIV\/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, , Kerman,","place":["Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Sadidi","sequence":"additional","affiliation":[{"name":"Kerman University of Medical Sciences HIV\/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, , Kerman,","place":["Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Khezri","sequence":"additional","affiliation":[{"name":"New York University Department of Epidemiology, School of Global Public Health, , New York, , , and HIV\/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Akbar","family":"Haghdoost","sequence":"additional","affiliation":[{"name":"Kerman University of Medical Sciences Modeling in Health Research Center, Institute for Futures Studies in Health, , Kerman,","place":["Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Tavakoli","sequence":"additional","affiliation":[{"name":"Kerman University of Medical Sciences Modeling in Health Research Center, Institute for Futures Studies in Health, , Kerman,","place":["Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elahe","family":"Amiri","sequence":"additional","affiliation":[{"name":"Kerman University of Medical Sciences Student Research Committee, , Kerman,","place":["Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Sharifi","sequence":"additional","affiliation":[{"name":"Kerman University of Medical Sciences HIV\/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, , Kerman, , and Knowledge Hub for Migrant and Refugee Health, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran","place":["Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Karamouzian","sequence":"additional","affiliation":[{"name":"University of Toronto Dalla Lana School of Public Health, , Toronto, ; Centre on Drug Policy Evaluation, MAP Centre for Urban Health Solutions, St. Michael\u2019s Hospital, Unity Health Toronto, Toronto, Canada and HIV\/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"140","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"issue":"3","key":"2026101208001725000_ref001","first-page":"51","article-title":"Triangular clinics: the way of the future","volume":"5","author":"Alavian","year":"2005","journal-title":"Hepatitis Monthly"},{"issue":"3","key":"2026101208001725000_ref002","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1108\/IJPH-03-2017-0016","article-title":"Drug injection within prison in Kyrgyzstan: elevated HIV risk and implications for scaling up opioid agonist treatments","volume":"14","author":"Azbel","year":"2018","journal-title":"International Journal of Prisoner Health"},{"issue":"1","key":"2026101208001725000_ref003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-015-1584-x","article-title":"A systematic review of the effectiveness and cost-effectiveness of peer education and peer support in prisons","volume":"15","author":"Bagnall","year":"2015","journal-title":"BMC Public Health"},{"issue":"12","key":"2026101208001725000_ref004","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1111\/add.15565","article-title":"Methadone and buprenorphine treatment in United States jails and prisons: lessons from early adopters","volume":"116","author":"Bandara","year":"2021","journal-title":"Addiction"},{"issue":"6","key":"2026101208001725000_ref005","doi-asserted-by":"crossref","first-page":"e557","DOI":"10.1016\/S2468-2667(22)00093-7","article-title":"The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations: a systematic review and meta-analysis","volume":"7","author":"Baranyi","year":"2022","journal-title":"The Lancet Public Health"},{"issue":"4","key":"2026101208001725000_ref006","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.1016\/S2214-109X(18)30539-4","article-title":"Severe mental illness and substance use disorders in prisoners in low-income and middle-income countries: a systematic review and meta-analysis of prevalence studies","volume":"7","author":"Baranyi","year":"2019","journal-title":"The Lancet Global Health"},{"issue":"1","key":"2026101208001725000_ref007","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12954-022-00721-6","article-title":"We want everything in a one-stop shop\u2019: acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for black people who inject drugs","volume":"19","author":"Bartholomew","year":"2022","journal-title":"Harm Reduction Journal"},{"key":"2026101208001725000_ref008","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.drugalcdep.2018.09.003","article-title":"Utilization of opioid agonist therapy among incarcerated persons with opioid use disorder in Vancouver, Canada","volume":"193","author":"Bozinoff","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"2026101208001725000_ref009","doi-asserted-by":"crossref","first-page":"110896","DOI":"10.1016\/j.drugalcdep.2023.110896","article-title":"Exploring mental health comorbidities and opioid agonist treatment coverage among people in prison: a national cohort study 2010\u20132019","volume":"250","author":"Bukten","year":"2023","journal-title":"Drug and Alcohol Dependence"},{"issue":"2S","key":"2026101208001725000_ref010","first-page":"1","article-title":"The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update","volume":"14","author":"Cunningham","year":"2020","journal-title":"Journal of Addiction Medicine"},{"key":"2026101208001725000_ref011","volume-title":"Evaluating the Effectiveness of Correctional Education: A Meta-Analysis of Programs That Provide Education to Incarcerated Adults","author":"Davis","year":"2013"},{"key":"2026101208001725000_ref012","volume-title":"Methods in Epidemiologic Research","author":"Dohoo","year":"2012"},{"issue":"7","key":"2026101208001725000_ref013","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1176\/appi.ps.20220310","article-title":"Peer health navigation experiences before and after prison release among people with opioid use disorder","volume":"74","author":"Enich","year":"2023","journal-title":"Psychiatric Services"},{"key":"2026101208001725000_ref014","unstructured":"Fair, H. and Walmsley, R. (2024), \u201cPrison populations continue to rise in many parts of the world, with 11.5 million held in prisons worldwide\u201d, Institute for Crime & Justice Policy Research (ICPR), University of London, available at:Link to the website of prisonstudies (accessed24 September 2024)."},{"issue":"9","key":"2026101208001725000_ref015","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/jamainternmed.2018.3504","article-title":"Implementing opioid agonist treatment in correctional facilities","volume":"178","author":"Fiscella","year":"2018","journal-title":"JAMA Internal Medicine"},{"key":"2026101208001725000_ref016","doi-asserted-by":"crossref","first-page":"102768","DOI":"10.1016\/j.drugpo.2020.102768","article-title":"A scoping review of barriers and facilitators to implementation of medications for treatment of opioid use disorder within the criminal justice system","volume":"81","author":"Grella","year":"2020","journal-title":"International Journal of Drug Policy"},{"issue":"3","key":"2026101208001725000_ref017","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1360-0443.2011.03676.x","article-title":"The effectiveness of opioid maintenance treatment in prison settings: a systematic review","volume":"107","author":"Hedrich","year":"2012","journal-title":"Addiction"},{"key":"2026101208001725000_ref018","doi-asserted-by":"crossref","DOI":"10.1002\/9781118548387","volume-title":"Applied Logistic Regression","author":"Hosmer","year":"2013","edition":"3rd ed."},{"key":"2026101208001725000_ref019","doi-asserted-by":"crossref","first-page":"107707","DOI":"10.1016\/j.drugalcdep.2019.107707","article-title":"Non-fatal drug overdose after release from prison: a prospective data linkage study","volume":"206","author":"Keen","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"key":"2026101208001725000_ref020","doi-asserted-by":"crossref","first-page":"102978","DOI":"10.1016\/j.drugpo.2020.102978","article-title":"A systematic review of qualitative evidence on barriers to and facilitators of the implementation of opioid agonist treatment (OAT) programmes in prisons","volume":"87","author":"Komalasari","year":"2021","journal-title":"International Journal of Drug Policy"},{"issue":"2","key":"2026101208001725000_ref021","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1108\/MHRJ-03-2021-0024","article-title":"The impact of integrating mental health services within a prison setting","volume":"27","author":"Kothari","year":"2022","journal-title":"Mental Health Review Journal"},{"issue":"12","key":"2026101208001725000_ref022","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1377\/hlthaff.2017.0890","article-title":"Only one in twenty justice-referred adults in specialty treatment for opioid use receive methadone or buprenorphine","volume":"36","author":"Krawczyk","year":"2017","journal-title":"Health Affairs"},{"key":"2026101208001725000_ref023","doi-asserted-by":"crossref","first-page":"103209","DOI":"10.1016\/j.drugpo.2021.103209","article-title":"Decisional considerations for methadone uptake in Kyrgyz prisons: the importance of understanding context and providing accurate information","volume":"94","author":"Liberman","year":"2021","journal-title":"International Journal of Drug Policy"},{"issue":"3","key":"2026101208001725000_ref024","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1027\/1614-2241.1.3.86","article-title":"Sufficient sample sizes for multilevel modeling","volume":"1","author":"Maas","year":"2005","journal-title":"Methodology"},{"issue":"9","key":"2026101208001725000_ref025","doi-asserted-by":"crossref","first-page":"e684","DOI":"10.1016\/S2468-2667(24)00160-9","article-title":"Interventions to reduce harms related to drug use among people who experience incarceration: systematic review and meta-analysis","volume":"9","author":"Macdonald","year":"2024","journal-title":"The Lancet Public Health"},{"key":"2026101208001725000_ref026","doi-asserted-by":"crossref","first-page":"209066","DOI":"10.1016\/j.josat.2023.209066","article-title":"Perceived access to opioid agonist treatment in prison among people with a history of injection drug use: a qualitative study","volume":"150","author":"Marshall","year":"2023","journal-title":"Journal of Substance Use and Addiction Treatment"},{"issue":"1_suppl","key":"2026101208001725000_ref027","doi-asserted-by":"crossref","first-page":"8S","DOI":"10.1177\/0033354919826563","article-title":"Linkages between incarceration and health","volume":"134","author":"Massoglia","year":"2019","journal-title":"Public Health Reports\u00ae"},{"issue":"2","key":"2026101208001725000_ref028","first-page":"179","article-title":"Drug use and unsafe injection among adults who live in prisons in Iran: a systematic review and meta-analysis","volume":"31","author":"Mehrabi","year":"2024","journal-title":"Drugs: Education, Prevention and Policy"},{"key":"2026101208001725000_ref029","doi-asserted-by":"crossref","first-page":"108088","DOI":"10.1016\/j.drugalcdep.2020.108088","article-title":"The relationship between incarceration history and overdose in North America: a scoping review of the evidence","volume":"213","author":"Mital","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"2026101208001725000_ref030","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2288-7-34","article-title":"A simulation study of sample size for multilevel logistic regression models","volume":"7","author":"Moineddin","year":"2007","journal-title":"BMC Medical Research Methodology"},{"key":"2026101208001725000_ref031","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jsat.2018.12.003","article-title":"Effectiveness of medication assisted treatment for opioid use in prison and jail settings: a meta-analysis and systematic review","volume":"99","author":"Moore","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"Suppl 3","key":"2026101208001725000_ref032","doi-asserted-by":"crossref","first-page":"iii33","DOI":"10.1136\/sextrans-2013-051295","article-title":"HIV prevalence and related risk behaviours among prisoners in Iran: results of the national biobehavioural survey, 2009","volume":"89","author":"Navadeh","year":"2013","journal-title":"Sexually Transmitted Infections"},{"issue":"1","key":"2026101208001725000_ref033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40352-017-0052-3","article-title":"Health care needs and service use among male prison inmates in the United States: a multi-level behavioral model of prison health service utilization","volume":"5","author":"Nowotny","year":"2017","journal-title":"Health and Justice"},{"issue":"4","key":"2026101208001725000_ref034","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1108\/IJPH-07-2020-0046","article-title":"Mental health interventions in an Italian prison: the Parma integrated approach","volume":"17","author":"Pelizza","year":"2021","journal-title":"International Journal of Prisoner Health"},{"key":"2026101208001725000_ref035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.drugpo.2015.12.016","article-title":"Accessing methadone within Moldovan prisons: prejudice and myths amplified by peers","volume":"29","author":"Polonsky","year":"2016","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"2026101208001725000_ref036","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12954-024-01072-0","article-title":"Non-injection drug use among incarcerated people in Iran: findings from three consecutive national bio-behavioral surveys","volume":"21","author":"Rafiee","year":"2024","journal-title":"Harm Reduction Journal"},{"issue":"1","key":"2026101208001725000_ref037","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s12889-022-12685-0","article-title":"Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study","volume":"22","author":"Russell","year":"2022","journal-title":"BMC Public Health"},{"issue":"4","key":"2026101208001725000_ref038","doi-asserted-by":"crossref","first-page":"e113989","DOI":"10.5812\/ijhrba.113989","article-title":"Substance use and the necessity for harm reduction programs in prisons: a qualitative study in Central Prison of Sanandaj, Iran","volume":"10","author":"Saberi Zafarghandi","year":"2021","journal-title":"International Journal of High Risk Behaviors and Addiction"},{"issue":"2","key":"2026101208001725000_ref039","first-page":"247","article-title":"Addiction treatment and harm reduction programs in prisons: lessons from Iran","volume":"21","author":"Saberi Zafarghandi","year":"2024","journal-title":"International Journal of Prison Health"},{"issue":"1","key":"2026101208001725000_ref040","doi-asserted-by":"crossref","first-page":"48","DOI":"10.32598\/ijpcp.27.1.3324.1","article-title":"Review, documentation, assessment of treatment, and harm reduction programs of substance use disorder in Iranian prisons","volume":"27","author":"Saberi Zafarghandi","year":"2021","journal-title":"Iranian Journal of Psychiatry and Clinical Psychology"},{"issue":"1","key":"2026101208001725000_ref041","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12954-022-00675-9","article-title":"HIV prevalence and continuum of care among incarcerated people in Iran from 2010 to 2017","volume":"19","author":"Shahesmaeili","year":"2022","journal-title":"Harm Reduction Journal"},{"issue":"3","key":"2026101208001725000_ref042","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jhep.2023.04.019","article-title":"A \u2018one-stop-shop\u2019 point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: the PIVOT study","volume":"79","author":"Sheehan","year":"2023","journal-title":"Journal of Hepatology"},{"issue":"1","key":"2026101208001725000_ref043","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12888-024-05736-w","article-title":"Breaking down barriers to mental healthcare access in prison: a qualitative interview study with incarcerated males in Norway","volume":"24","author":"Solbakken","year":"2024","journal-title":"BMC Psychiatry"},{"issue":"2","key":"2026101208001725000_ref044","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/add.15640","article-title":"Jail and overdose: assessing the community impact of incarceration on overdose","volume":"117","author":"Victor","year":"2022","journal-title":"Addiction"},{"key":"2026101208001725000_ref045","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3389\/fpsyt.2020.00794","article-title":"Prevalence of opioid dependence and opioid agonist treatment in the Berlin custodial setting: a cross-sectional study","volume":"11","author":"von Bernuth","year":"2020","journal-title":"Frontiers in Psychiatry"},{"issue":"1","key":"2026101208001725000_ref046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40352-020-00122-6","article-title":"Making change happen in criminal justice settings: leveraging implementation science to improve mental health care","volume":"8","author":"Zielinski","year":"2020","journal-title":"Health and Justice"}],"container-title":["International Journal of Prison Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.emerald.com\/ijoph\/article-pdf\/22\/3\/451\/11702361\/ijoph-10-2025-0087en.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.emerald.com\/ijoph\/article-pdf\/22\/3\/451\/11702361\/ijoph-10-2025-0087en.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:00:28Z","timestamp":1791806428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.emerald.com\/ijoph\/article\/22\/3\/451\/1382310\/Unmet-needs-for-opioid-agonist-therapy-in-Iranian"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,10,13]]}},"URL":"https:\/\/doi.org\/10.1108\/ijoph-10-2025-0087","relation":{},"ISSN":["2977-0254","2977-0262"],"issn-type":[{"value":"2977-0254","type":"print"},{"value":"2977-0262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]}}}